skip to main
|
skip to sidebar
Personalized medicine
mardi 15 juin 2010
What Five FDA Letters Mean for the Future of DTC Genetic Testing
A
interesting post
from Dan Vorhaus at
genomicslawreport.com
.
Aucun commentaire:
Enregistrer un commentaire
Article plus récent
Article plus ancien
Accueil
Inscription à :
Publier les commentaires (Atom)
Membres
Archives du blog
►
2011
(4)
►
février
(4)
▼
2010
(41)
►
septembre
(1)
►
août
(1)
►
juillet
(5)
▼
juin
(23)
SNPedia, a wiki dedicated to human SNPs
Genome-wide association mapping and rare alleles: ...
Personalized Therapy at AACR
Genome project at Kaiser: From Californians’ DNA,...
Biology 2.0
The next advances in genomics may happen in China
No predicting value of 100 genetic variants linked...
Geneticist George Church: Sequencing human genome ...
Susceptibility loci for Alzheimer disease
What Five FDA Letters Mean for the Future of DTC G...
Genetic Testing Companies in San Diego, Boston, & ...
A Decade Later, Genetic Map Yields Few New Cures
F.D.A. Faults Companies on Unapproved Genetic Tests
Autism Genome Project Consortium Implicates Rare C...
Illumina Slashes Cost of Individual Genome Sequenc...
On a Mission to Sequence the Genomes of 100,000 Pe...
The Genome 10K project
The Personal genome project
100 genetic risks by genome
What is the Cost of Human Genome Sequencing?
New susceptibility loci for nasopharyngeal carcinoma
New Genetic Associations Revealed for Nasopharynge...
What is the number of genes in the human genome ?
►
mai
(5)
►
avril
(1)
►
mars
(2)
►
janvier
(3)
►
2009
(1)
►
octobre
(1)
►
2008
(1)
►
octobre
(1)
►
2006
(1)
►
juillet
(1)
Aucun commentaire:
Enregistrer un commentaire